Prospective randomized clinical trial of primary treatment in breast cancer stages T3/4, N+/-, MO. Chemotherapy vs. radiotherapy. Arbeitskreis für Perioperative Chemotherapie.

Author: RainerH

Paper Details 
Original Abstract of the Article :
209 patients entered a randomized trial. We compared a) pre- and postoperative chemotherapy (= treatment A) [5-drug combination chemotherapy+tamoxifen] versus b) pre- and postoperative radiotherapy (= treatment B). Nonresponders to preoperative chemotherapy were << crossed over >> to postoperative r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/8267401

データ提供:米国国立医学図書館(NLM)

Chemotherapy vs. Radiotherapy in Breast Cancer: A Race Against Time

Breast cancer is a formidable foe, and the search for effective treatments is a race against time. This study dives into the desert of breast cancer research, focusing on the comparison of chemotherapy and radiotherapy in the treatment of advanced stages of the disease. The researchers conducted a randomized trial, a method as precise as a compass guiding a caravan across the dunes, to compare the effectiveness of pre- and postoperative chemotherapy with pre- and postoperative radiotherapy in patients with breast cancer stages T3/4, N+/-, MO.

Chemotherapy Shows Promise in Advanced Breast Cancer

The study's findings indicate that chemotherapy, like a strong camel navigating treacherous terrain, demonstrated superior relapse-free survival and overall survival rates compared to radiotherapy. This discovery is like finding a hidden spring in the desert, offering a potential source of hope for patients with advanced breast cancer. However, it's important to note that the study also found that responders to chemotherapy had significantly better outcomes than non-responders, highlighting the need for personalized treatment approaches.

Breast Cancer Treatment: A Journey Through the Desert

This study emphasizes the need for personalized treatment approaches in breast cancer, taking into account individual patient characteristics and response to treatment. It's a reminder that the desert of breast cancer research is vast and complex, and we must continue to explore its landscape, searching for oases of effective treatment and solutions.

Dr.Camel's Conclusion

The race against time in breast cancer treatment continues, with this study offering valuable insights into the effectiveness of chemotherapy. It's a reminder that the desert of breast cancer research is vast, and we must continue to explore its landscape, searching for oases of effective treatment and solutions for all patients.

Date :
  1. Date Completed 1994-01-21
  2. Date Revised 2004-11-17
Further Info :

Pubmed ID

8267401

DOI: Digital Object Identifier

8267401

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.